The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada—1997 results from the SENTRY Antimicrobial Surveillance Program
- 31 December 1998
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 32 (4), 313-316
- https://doi.org/10.1016/s0732-8893(98)00081-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validationDiagnostic Microbiology and Infectious Disease, 1999
- Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates ofStreptococcus pneumoniaein North America: 1997 Results from the SENTRY Antimicrobial Surveillance ProgramClinical Infectious Diseases, 1998
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USADiagnostic Microbiology and Infectious Disease, 1997
- In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisAntimicrobial Agents and Chemotherapy, 1997
- Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 1996
- Evaluation of OPC-17116 against important pathogens that cause respiratory tract infectionsAntimicrobial Agents and Chemotherapy, 1994
- North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin: A 53-medical-center sample of spectra of activityDiagnostic Microbiology and Infectious Disease, 1994
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1993
- Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990